Impact of COVID-19 Outbreak on Plasma-derived Therapies, Global Market Research Report 2020

Impact of COVID-19 Outbreak on Plasma-derived Therapies, Global Market Research Report 2020

May 2020 QYResearch ICT93 Pages Price :
$ 3900
This report focuses on the global Plasma-derived Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasma-derived Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols

Market segment by Type, the product can be split into
Albumin
Immunoglobulin
Factor VIII
Others
Market segment by Application, split into
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Plasma-derived Therapies status, future forecast, growth opportunity, key market and key players.
To present the Plasma-derived Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Plasma-derived Therapies are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Plasma-derived Therapies Revenue
1.4 Market Analysis by Type
1.4.1 Global Plasma-derived Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Albumin
1.4.3 Immunoglobulin
1.4.4 Factor VIII
1.4.5 Others
1.5 Market by Application
1.5.1 Global Plasma-derived Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hemophilia
1.5.3 Primary Immunodeficiencies (PIDs)
1.5.4 Idiopathic Thrombocytopenic Purpura (ITP)
1.5.5 COVID-19
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Plasma-derived Therapies Industry Impact
1.6.1 How the Covid-19 is Affecting the Plasma-derived Therapies Industry
1.6.1.1 Plasma-derived Therapies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Plasma-derived Therapies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Plasma-derived Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 Plasma-derived Therapies Market Perspective (2015-2026)
2.2 Plasma-derived Therapies Growth Trends by Regions
2.2.1 Plasma-derived Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Plasma-derived Therapies Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
3.1 Plasma-derived Therapies Revenue by Players (2019-2020)
3.2 Plasma-derived Therapies Key Players Head office and Area Served
3.3 Key Players Plasma-derived Therapies Product/Solution/Service
3.4 Date of Enter into Plasma-derived Therapies Market
3.5 Key Players Plasma-derived Therapies Funding/Investment Analysis
3.6 Global Key Players Plasma-derived Therapies Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Global Plasma-derived Therapies Market Size by Type (2019-2026)

5 Global Plasma-derived Therapies Market Size by Application (2019-2026)

6 North America
6.1 North America Plasma-derived Therapies Market Forecast (2019-2026)
6.2 Plasma-derived Therapies Key Players in North America (2019-2020)
6.3 North America Plasma-derived Therapies Market Size by Type (2015-2020)
6.4 North America Plasma-derived Therapies Market Size by Application (2015-2020)

7 Europe
7.1 Europe Plasma-derived Therapies Market Forecast (2019-2026)
7.2 Plasma-derived Therapies Key Players in Europe (2019-2020)
7.3 Europe Plasma-derived Therapies Market Size by Type (2015-2020)
7.4 Europe Plasma-derived Therapies Market Size by Application (2015-2020)

8 China
8.1 China Plasma-derived Therapies Market Forecast (2019-2026)
8.2 Plasma-derived Therapies Key Players in China (2019-2020)
8.3 China Plasma-derived Therapies Market Size by Type (2015-2020)
8.4 China Plasma-derived Therapies Market Size by Application (2015-2020)

9 Japan
9.1 Japan Plasma-derived Therapies Market Forecast (2019-2026)
9.2 Plasma-derived Therapies Key Players in Japan (2019-2020)
9.3 Japan Plasma-derived Therapies Market Size by Type (2015-2020)
9.4 Japan Plasma-derived Therapies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Plasma-derived Therapies Market Forecast (2019-2026)
10.2 Plasma-derived Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Plasma-derived Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Plasma-derived Therapies Market Size by Application (2015-2020)

11 India
11.1 India Plasma-derived Therapies Market Forecast (2019-2026)
11.2 Plasma-derived Therapies Key Players in India (2019-2020)
11.3 India Plasma-derived Therapies Market Size by Type (2015-2020)
11.4 India Plasma-derived Therapies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Plasma-derived Therapies Market Forecast (2019-2026)
12.2 Plasma-derived Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Plasma-derived Therapies Market Size by Type (2015-2020)
12.4 Central & South America Plasma-derived Therapies Market Size by Application (2015-2020)

13Key Players Profiles
13.1 CSL Behring LLC
13.1.1 CSL Behring LLC Company Details
13.1.2 CSL Behring LLC Business Overview and Its Total Revenue
13.1.3 CSL Behring LLC Plasma-derived Therapies Introduction
13.1.4 CSL Behring LLC Revenue in Plasma-derived Therapies Business (2019-2020))
13.1.5 CSL Behring LLC Recent Development
13.2 Shire
13.2.1 Shire Company Details
13.2.2 Shire Business Overview and Its Total Revenue
13.2.3 Shire Plasma-derived Therapies Introduction
13.2.4 Shire Revenue in Plasma-derived Therapies Business (2019-2020))
13.2.5 Shire Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview and Its Total Revenue
13.3.3 Bayer Plasma-derived Therapies Introduction
13.3.4 Bayer Revenue in Plasma-derived Therapies Business (2019-2020))
13.3.5 Bayer Recent Development
13.4 Kedrion
13.4.1 Kedrion Company Details
13.4.2 Kedrion Business Overview and Its Total Revenue
13.4.3 Kedrion Plasma-derived Therapies Introduction
13.4.4 Kedrion Revenue in Plasma-derived Therapies Business (2019-2020))
13.4.5 Kedrion Recent Development
13.5 Takeda
13.5.1 Takeda Company Details
13.5.2 Takeda Business Overview and Its Total Revenue
13.5.3 Takeda Plasma-derived Therapies Introduction
13.5.4 Takeda Revenue in Plasma-derived Therapies Business (2019-2020))
13.5.5 Takeda Recent Development
13.6 Biotest
13.6.1 Biotest Company Details
13.6.2 Biotest Business Overview and Its Total Revenue
13.6.3 Biotest Plasma-derived Therapies Introduction
13.6.4 Biotest Revenue in Plasma-derived Therapies Business (2019-2020))
13.6.5 Biotest Recent Development
13.7 Octaparma
13.7.1 Octaparma Company Details
13.7.2 Octaparma Business Overview and Its Total Revenue
13.7.3 Octaparma Plasma-derived Therapies Introduction
13.7.4 Octaparma Revenue in Plasma-derived Therapies Business (2019-2020))
13.7.5 Octaparma Recent Development
13.8 Bio Products Laboratory (BPL)
13.8.1 Bio Products Laboratory (BPL) Company Details
13.8.2 Bio Products Laboratory (BPL) Business Overview and Its Total Revenue
13.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Introduction
13.8.4 Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business (2019-2020))
13.8.5 Bio Products Laboratory (BPL) Recent Development
13.9 LFB
13.9.1 LFB Company Details
13.9.2 LFB Business Overview and Its Total Revenue
13.9.3 LFB Plasma-derived Therapies Introduction
13.9.4 LFB Revenue in Plasma-derived Therapies Business (2019-2020))
13.9.5 LFB Recent Development
13.10 Grifols
13.10.1 Grifols Company Details
13.10.2 Grifols Business Overview and Its Total Revenue
13.10.3 Grifols Plasma-derived Therapies Introduction
13.10.4 Grifols Revenue in Plasma-derived Therapies Business (2019-2020))
13.10.5 Grifols Recent Development

14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porters Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables
Table 1. Plasma-derived Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Plasma-derived Therapies Revenue
Table 3. Ranking of Global Top Plasma-derived Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Plasma-derived Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Albumin
Table 6. Key Players of Immunoglobulin
Table 7. Key Players of Factor VIII
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Plasma-derived Therapies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Plasma-derived Therapies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Plasma-derived Therapies Players to Combat Covid-19 Impact
Table 14. Global Plasma-derived Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Plasma-derived Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Plasma-derived Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Plasma-derived Therapies Market Share by Regions 2019-2026
Table 18. Market Top Trends
Table 19. Market Use Cases
Table 20. Global Plasma-derived Therapies Revenue by Players (2019-2020) (Million US$)
Table 21. Global Plasma-derived Therapies Market Share by Players (2019-2020)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Plasma-derived Therapies Product Solution and Service
Table 24. Date of Enter into Plasma-derived Therapies Market
Table 25. Global Key Players Plasma-derived Therapies Funding/Investment Analysis (Million USD)
Table 26. Global Key Players Plasma-derived Therapies Valuation & Market Capitalization (Million USD)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 29. Global Plasma-derived Therapies Market Size Share by Type (2019-2026)
Table 30. Global Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 31. Global Plasma-derived Therapies Market Size Share by Application (2019-2026)
Table 32. North America Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 34. North America Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 35. North America Plasma-derived Therapies Market Share by Type (2019-2026)
Table 36. North America Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 37. North America Plasma-derived Therapies Market Share by Application (2019-2026)
Table 38. Europe Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 40. Europe Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 41. Europe Plasma-derived Therapies Market Share by Type (2019-2026)
Table 42. Europe Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 43. Europe Plasma-derived Therapies Market Share by Application (2019-2026)
Table 44. China Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 45. China Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 46. China Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 47. China Plasma-derived Therapies Market Share by Type (2019-2026)
Table 48. China Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 49. China Plasma-derived Therapies Market Share by Application (2019-2026)
Table 50. Japan Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 52. Japan Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 53. Japan Plasma-derived Therapies Market Share by Type (2019-2026)
Table 54. Japan Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 55. Japan Plasma-derived Therapies Market Share by Application (2019-2026)
Table 56. Southeast Asia Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 58. Southeast Asia Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 59. Southeast Asia Plasma-derived Therapies Market Share by Type (2019-2026)
Table 60. Southeast Asia Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 61. Southeast Asia Plasma-derived Therapies Market Share by Application (2019-2026)
Table 62. India Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 63. India Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 64. India Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 65. India Plasma-derived Therapies Market Share by Type (2019-2026)
Table 66. India Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 67. India Plasma-derived Therapies Market Share by Application (2019-2026)
Table 68. Central & South America Key Players Plasma-derived Therapies Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Plasma-derived Therapies Market Share (2019-2020)
Table 70. Central & South America Plasma-derived Therapies Market Size by Type (2019-2026) (Million US$)
Table 71. Central & South America Plasma-derived Therapies Market Share by Type (2019-2026)
Table 72. Central & South America Plasma-derived Therapies Market Size by Application (2019-2026) (Million US$)
Table 73. Central & South America Plasma-derived Therapies Market Share by Application (2019-2026)
Table 74. CSL Behring LLC Company Details
Table 75. CSL Behring LLC Business Overview
Table 76. CSL Behring LLC Product
Table 77. Company Description and Business Overview
Table 78. CSL Behring LLC Plasma-derived Therapies Product
Table 79. CSL Behring LLC Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 80. CSL Behring LLC Recent Development
Table 81. Shire Company Details
Table 82. Shire Business Overview
Table 83. Shire Product
Table 84. Company Description and Business Overview
Table 85. Shire Plasma-derived Therapies Product
Table 86. Shire Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 87. Shire Recent Development
Table 88. Bayer Company Details
Table 89. Bayer Business Overview
Table 90. Bayer Product
Table 91. Company Description and Business Overview
Table 92. Bayer Plasma-derived Therapies Product
Table 93. Bayer Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 94. Bayer Recent Development
Table 95. Kedrion Company Details
Table 96. Kedrion Business Overview
Table 97. Kedrion Product
Table 98. Company Description and Business Overview
Table 99. Kedrion Plasma-derived Therapies Product
Table 100. Kedrion Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 101. Kedrion Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Product
Table 105. Company Description and Business Overview
Table 106. Takeda Plasma-derived Therapies Product
Table 107. Takeda Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 108. Takeda Recent Development
Table 109. Biotest Company Details
Table 110. Biotest Business Overview
Table 111. Biotest Product
Table 112. Company Description and Business Overview
Table 113. Biotest Plasma-derived Therapies Product
Table 114. Biotest Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 115. Biotest Recent Development
Table 116. Octaparma Company Details
Table 117. Octaparma Business Overview
Table 118. Octaparma Product
Table 119. Company Description and Business Overview
Table 120. Octaparma Plasma-derived Therapies Product
Table 121. Octaparma Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 122. Octaparma Recent Development
Table 123. Bio Products Laboratory (BPL) Business Overview
Table 124. Bio Products Laboratory (BPL) Product
Table 125. Bio Products Laboratory (BPL) Company Details
Table 126. Company Description and Business Overview
Table 127. Bio Products Laboratory (BPL) Plasma-derived Therapies Product
Table 128. Bio Products Laboratory (BPL) Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 129. Bio Products Laboratory (BPL) Recent Development
Table 130. LFB Company Details
Table 131. LFB Business Overview
Table 132. LFB Product
Table 133. Company Description and Business Overview
Table 134. LFB Plasma-derived Therapies Product
Table 135. LFB Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 136. LFB Recent Development
Table 137. Grifols Company Details
Table 138. Grifols Business Overview
Table 139. Grifols Product
Table 140. Company Description and Business Overview
Table 141. Grifols Plasma-derived Therapies Product
Table 142. Grifols Revenue in Plasma-derived Therapies Business 2019 and 2020 (Million US$)
Table 143. Grifols Recent Development
Table 144. Company Description and Business Overview
Table 145. Company Description and Business Overview
Table 146. Company Description and Business Overview
Table 147. Company Description and Business Overview
Table 148. Company Description and Business Overview
Table 149. Company Description and Business Overview
Table 150. Company Description and Business Overview
Table 151. Company Description and Business Overview
Table 152. Company Description and Business Overview
Table 153. Company Description and Business Overview
Table 154. Company Description and Business Overview
Table 155. Company Description and Business Overview
Table 156. Company Description and Business Overview
Table 157. Company Description and Business Overview
Table 158. Company Description and Business Overview
Table 159. Company Description and Business Overview
Table 160. Company Description and Business Overview
Table 161. Company Description and Business Overview
Table 162. Company Description and Business Overview
Table 163. Company Description and Business Overview
Table 164. Company Description and Business Overview
Table 165. Company Description and Business Overview
Table 166. Company Description and Business Overview
Table 167. Company Description and Business Overview
Table 168. Company Description and Business Overview
Table 169. Company Description and Business Overview
Table 170. Company Description and Business Overview
Table 171. Company Description and Business Overview
Table 172. Company Description and Business Overview
Table 173. Company Description and Business Overview
Table 174. Key Drivers: Impact Analysis (2021-2026)
Table 175. Key Opportunities
Table 176. Key Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma-derived Therapies Market Share by Type: 2020 VS 2026
Figure 2. Albumin Features
Figure 3. Immunoglobulin Features
Figure 4. Factor VIII Features
Figure 5. Others Features
Figure 6. Global Plasma-derived Therapies Market Share by Application: 2020 VS 2026
Figure 7. Hemophilia Case Studies
Figure 8. Primary Immunodeficiencies (PIDs) Case Studies
Figure 9. Idiopathic Thrombocytopenic Purpura (ITP) Case Studies
Figure 10. COVID-19 Case Studies
Figure 11. Others Case Studies
Figure 12. Plasma-derived Therapies Report Years Considered
Figure 13. Global Plasma-derived Therapies and Growth Rate (2019-2026) (Million US$)
Figure 14. Global Plasma-derived Therapies Market Share by Regions (2019-2026)
Figure 15. Global Plasma-derived Therapies Market Share by Players in 2019
Figure 16. Global Plasma-derived Therapies Market Size Market Share by Type (2019-2026)
Figure 17. Global Plasma-derived Therapies Market Size Market Share by Application (2019-2026)
Figure 18. North America Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. Europe Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. China Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Japan Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. Southeast Asia Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 23. India Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 24. Central & South America Plasma-derived Therapies Market Size YoY Growth (2019-2026) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top